HIMS (Hims & Hers Health) Short-Term Debt: $0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HIMS Hims & Hers Health Inc HIMS
83 GF Score
Price $34.83
GF Value $39.46
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Short-Term Debt?

Hims & Hers Health HIMS +1.31% 83 Short-Term Debt is $0 Mil as of Mar. 2026. GuruFocus rates HIMS with a GF Score™ of 83/100 and a GF Value™ of $39.46 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hims & Hers Health's Short-Term Debt for the quarter that ended in Mar. 2026 was $0 Mil.

Hims & Hers Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Hims & Hers Health Short-Term Debt Related Terms

Hims & Hers Health Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Short-Term Debt Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HIMS
83GF Score
Hims & Hers Health Inc HIMS
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0 Mil mean?
Hims & Hers Health (HIMS) has a Short-Term Debt of $0 Mil as of Mar. 2026.
Is Hims & Hers Health's Short-Term Debt too high?
Hims & Hers Health's current Short-Term Debt is $0 Mil. Overall, Hims & Hers Health has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Short-Term Debt compare to LNTH and LQDA?
Hims & Hers Health's Short-Term Debt of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Hims & Hers Health's current Short-Term Debt is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.46, compared to a current price of $34.83 — trading 11.7% below its estimated fair value. The current Short-Term Debt is $0 Mil. Hims & Hers Health's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Short-Term Debt is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of $34.83 is trading 11.7% below its estimated GF Value™ of $39.46. GuruFocus considers Hims & Hers Health to be Modestly Undervalued.

Key valuation signals for HIMS:

  • Short-Term Debt: $0 Mil
  • GF Value™: $39.46 vs. price of $34.83 (11.7% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Other Exchanges HIMS:Mexico82W:Germany
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
83GF Score

Get the complete analysis for HIMS

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.83
Price
$39.46
GF Value